Literature DB >> 30580313

Pars plana vitrectomy in management of giant retinal tear and retinal detachment following iris-fixated anterior chamber phakic intraocular lens implantation.

Sagnik Sen1, Raghav Dinesh Ravani1, Prateek Kakkar1, Atul Kumar1.   

Abstract

This case report describes a 26-year-old man presenting with a giant retinal tear (GRT) with retinal detachment (RD) following implantation of iris-fixated anterior chamber phakic intraocular lens (AC-PIOL) for high myopia and occurrence of intraoperative aberrations during vitrectomy due to the presence of AC-PIOL in situ. Posterior chamber PIOL have been well reported to be associated with GRT with RD. Very few reports exist of GRT with RD following AC-PIOL. Moreover, the presence of iris-fixated AC-PIOL, in this case, led to the formation of ghost images intraoperatively especially during crucial steps like induction of posterior vitreous detachment which has never been reported. © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  anterior chamber; retina; visual pathway

Mesh:

Year:  2018        PMID: 30580313      PMCID: PMC6350697          DOI: 10.1136/bcr-2018-228052

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Bilateral giant tear-associated retinal detachment following Artisan phakic intraocular lens implantation for correction of moderate myopia.

Authors:  Ilias Georgalas; Petros Petrou; Dimitris Papaconstantinou; Chrysanthi Koutsandrea; Ioannis Ladas
Journal:  Acta Ophthalmol       Date:  2009-06-22       Impact factor: 3.761

2.  Rhegmatogenous retinal detachment in phakic eyes after posterior chamber phakic intraocular lens implantation for severe myopia.

Authors:  Vicente Martínez-Castillo; Anna Boixadera; Alicia Verdugo; Daniel Elíes; Andrés Coret; José García-Arumí
Journal:  Ophthalmology       Date:  2005-04       Impact factor: 12.079

3.  Relationships between vitreoretinal and refractive surgery.

Authors:  G Panozzo; B Parolini
Journal:  Ophthalmology       Date:  2001-09       Impact factor: 12.079

4.  U.S. Food and Drug Administration clinical trial of the Implantable Contact Lens for moderate to high myopia.

Authors:  Donald R Sanders; John A Vukich; Kimberley Doney; Monica Gaston
Journal:  Ophthalmology       Date:  2003-02       Impact factor: 12.079

5.  Staar Collamer posterior chamber phakic intraocular lens to correct myopia and hyperopia.

Authors:  E Rosen; C Gore
Journal:  J Cataract Refract Surg       Date:  1998-05       Impact factor: 3.351

6.  Phakic intraocular lenses to correct high myopia: Adatomed, Staar, and Artisan.

Authors:  José L Menezo; Cristina Peris-Martínez; Angel L Cisneros; Rafael Martínez-Costa
Journal:  J Cataract Refract Surg       Date:  2004-01       Impact factor: 3.351

7.  Giant retinal tear after iris claw phakic intraocular lens.

Authors:  María Concepción Hernáez-Ortega; Enrique Soto-Pedre
Journal:  J Refract Surg       Date:  2004 Nov-Dec       Impact factor: 3.573

8.  Retinal detachment in myopic eyes after phakic intraocular lens implantation.

Authors:  José Maria Ruiz-Moreno; Javier A Montero; Concepción de la Vega; Jorge L Alió; Pedro Zapater
Journal:  J Refract Surg       Date:  2006-03       Impact factor: 3.573

9.  Posterior chamber phakic intraocular lens for myopia of -8 to -19 diopters.

Authors:  R Zaldivar; J M Davidorf; S Oscherow
Journal:  J Refract Surg       Date:  1998 May-Jun       Impact factor: 3.573

  9 in total
  2 in total

1.  Artisan versus Artiflex phakic intraocular lens implantation in the treatment of moderate to high myopia: meta-analysis.

Authors:  Chenting Hou; Hui Li; Jiangfeng Li; Jinjian Li; Hui Peng; Qing Wang
Journal:  BMC Ophthalmol       Date:  2021-04-10       Impact factor: 2.209

2.  Comparison of rigid versus foldable iris-fixed phakic intraocular lens implantation for high myopia: A systematic review and meta-analysis.

Authors:  Qiong Wu; Yan Li; Li Tang; Li-An Wu; Cong-Yi Wang
Journal:  Medicine (Baltimore)       Date:  2020-02       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.